Target intelligence / Profile preview

Bacterial RNA polymerase switch region (RNAP switch region)

Target
RNAP switch region
Molecular classification
Enzyme, DNA-directed RNA polymerase, Bacterial protein
01

Overview

The bacterial RNA polymerase (RNAP) switch region is a vital regulatory hinge located at the base of the enzyme's clamp module. This region mediates the conformational changes—specifically the opening and closing of the clamp—that are required to permit DNA entry into the active site and to stabilize the transcription complex (Mukhopadhyay et al., 2008, Cell). As a target for antimicrobial therapy, the switch region is highly valued because it is essential for bacterial viability and is structurally distinct from the corresponding regions in human RNA polymerases, ensuring high selectivity (Belogurov et al., 2009, Nature). Small molecule inhibitors such as myxopyronin and corallopyronin bind to this site, effectively jamming the hinge and preventing the enzyme from initiating the transcription process (Srivastava et al., 2011, Curr Opin Microbiol). This mechanism of action is distinct from that of rifamycins, which bind to the RNA exit channel, making switch region inhibitors effective against many rifampin-resistant strains. Consequently, this target is a focal point for the development of next-generation antibiotics aimed at treating multidrug-resistant bacterial infections.

Other names
Switch region of bacterial RNA polymeraseRNAP switch regionRNAP clamp switchMyxopyronin binding siteSwitch 1 and Switch 2 regions of RNAP
02

Mechanism of action

Inhibition of transcription initiation by binding to the switch region and preventing the conformational changes (opening/closing) of the RNAP clamp required for DNA binding.

03

Biological functions

Transcription initiationRNA synthesisGene expression regulationConformational regulation of the RNA polymerase clamp
04

Disease associations

Bacterial infectionTuberculosisMultidrug-resistant bacterial infection
05

Safety considerations

Development of target-site mutations (e.g., in rpoB or rpoC genes)Limited clinical data on systemic toxicity in humansBioavailability challenges for current lead compounds
06

Interacting drugs

Myxopyronin A

2 more in the full profile.

07

Biomarkers

Bacterial RNA expression levelsMinimum inhibitory concentration (MIC)Bacterial load reduction

Beyond the preview

Go deeper on Bacterial RNA polymerase switch region (RNAP switch region).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial RNA polymerase switch region (RNAP switch region).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call